Juvenile myelomonocytic leukemia; moving forward
Leukemia
.
2023 Mar;37(3):720-722.
doi: 10.1038/s41375-023-01818-y.
Epub 2023 Jan 20.
Authors
M Tarek Elghetany
1
,
Hélène Cavé
2
,
Rita De Vito
3
,
Mrinal M Patnaik
4
,
Eric Solary
5
,
Joseph D Khoury
6
Affiliations
1
Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. txelghet@texaschildrens.org.
2
Université Paris Cité, Institut de recherche Saint-Louis and the Department of Genetics, Robert Debré Hospital, Paris, France.
3
Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, Rome, Italy.
4
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
5
Department of Hematology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France.
6
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
PMID:
36670234
DOI:
10.1038/s41375-023-01818-y
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Leukemia, Myelomonocytic, Juvenile* / genetics
Leukemia, Myelomonocytic, Juvenile* / therapy